Quarterly results · BIOCON

BIOCON LIMITED. Quarterly Results (BIOCON) — Q1 FY27

BIOCON LIMITED. reported revenue of ₹4,292 cr and net profit of ₹141 cr in Q1 FY27 (quarter ended 30 Jun 2026), +349.4% year on year. Below is the full quarter-wise results table with revenue, operating profit, margins, tax, EPS and annual history — updated automatically from exchange filings.

Next results date

Awaiting intimation

BIOCON Q1 FY27 results at a glance

BIOCON LIMITED. Q1 FY27 key results metrics
QuarterQ1 FY27
Quarter ended30 Jun 2026
Revenue₹4,292 cr
Revenue YoY+9.8%
Operating profit₹300 cr
Operating margin7.0%
Net profit₹141 cr
Net profit YoY+349.4%
Net profit QoQ+12.1%
Net margin3.3%
Basic EPS₹0.87
TTM revenue₹17,212 cr
TTM net profit₹495 cr
TTM net margin2.9%

BIOCON Q1 FY27 results: what the numbers say

BIOCON LIMITED. (BIOCON) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹4,292 cr and a net profit of ₹141 cr, translating into earnings per share of ₹0.87.

Compared with the same quarter a year earlier, revenue grew by +9.8% and net profit grew sharply by +349.4%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.

Operating profit for the quarter stood at ₹300 cr, an operating margin of 7.0% versus 8.0% a year ago — a contraction of 1.0 percentage points.

BIOCON quarter-wise results table

Revenue

₹4,292 cr

+9.8% YoY

Net profit

₹141 cr

+349.4% YoY

Operating profit

₹300 cr

-3.6% YoY

EPS

₹0.87

+234.6% YoY

BIOCON LIMITED. (BIOCON) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth
QuarterRevenueOperating profitNet profitOPMNet marginEPSProfit YoYProfit QoQ
Q1 FY272026-06-30₹4,292 cr₹300 cr₹141 cr7.0%3.3%₹0.87+349.4%+12.1%
Q4 FY262026-03-31₹4,484 cr₹507 cr₹126 cr11.3%2.8%₹0.79-12.4%
Q3 FY262025-12-31₹4,173 cr₹318 cr₹144 cr7.6%3.4%₹1.08+70.2%
Q2 FY262025-09-30₹4,263 cr₹362 cr₹84.5 cr8.5%2.0%₹0.66+169.1%
Q1 FY262025-06-30₹3,910 cr₹311 cr₹31.4 cr8.0%0.8%₹0.26
TTM (last 4 quarters)₹17,212 cr₹1,487 cr₹495 cr8.6%2.9%₹3.40

Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.

BIOCON quarterly income statement

Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.

BIOCON LIMITED. quarterly income statement
ParticularsQ1 FY272026-06-30Q4 FY262026-03-31Q3 FY262025-12-31Q2 FY262025-09-30Q1 FY262025-06-30
Revenue / Sales₹4,292 cr₹4,484 cr₹4,173 cr₹4,263 cr₹3,910 cr
Total expenses₹3,992 cr₹3,977 cr₹3,855 cr₹3,900 cr₹3,599 cr
Gross profit₹2,824 cr
Operating profit (EBIT)₹300 cr₹507 cr₹318 cr₹362 cr₹311 cr
Operating margin7.0%11.3%7.6%8.5%8.0%
Interest cost₹213 cr₹232 cr₹210 cr₹272 cr₹277 cr
Profit before tax₹128 cr₹248 cr-₹67.8 cr₹171 cr₹96.9 cr
Tax expense-₹9.2 cr₹48.9 cr-₹16 cr₹38.5 cr₹7.7 cr
Effective tax rate-7.2%19.8%23.6%22.5%7.9%
Net profit (PAT)₹141 cr₹126 cr₹144 cr₹84.5 cr₹31.4 cr
Net profit margin3.3%2.8%3.4%2.0%0.8%
Basic EPS₹0.87₹0.79₹1.08₹0.66₹0.26
Diluted EPS₹0.87₹0.79₹1.07₹0.65₹0.26

BIOCON results growth — YoY and QoQ

Quarterly growth rates, year on year and quarter on quarter
GrowthQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26
Revenue YoY+9.8%
Revenue QoQ-4.3%+7.5%-2.1%+9.0%
Operating profit YoY-3.6%
Operating profit QoQ-40.9%+59.3%-12.2%+16.5%
Net profit YoY+349.4%
Net profit QoQ+12.1%-12.4%+70.2%+169.1%
EPS YoY+234.6%
EPS QoQ+10.1%-26.9%+63.6%+153.8%

BIOCON annual results history

Full-year performance for BIOCON LIMITED., useful for reading each quarter in context.

BIOCON LIMITED. annual income statement
ParticularsFY262026-03-31FY252025-03-31FY242024-03-31FY232023-03-31
Revenue / Sales₹16,780 cr₹15,052 cr₹14,196 cr₹10,934 cr
Total expenses₹15,058 cr₹13,426 cr₹12,761 cr₹9,307 cr
Gross profit₹11,085 cr₹9,854 cr₹9,289 cr₹7,267 cr
Operating profit (EBIT)₹1,722 cr₹1,626 cr₹1,435 cr₹1,627 cr
Operating margin10.3%10.8%10.1%14.9%
Interest cost₹965 cr₹888 cr₹974 cr₹419 cr
Profit before tax₹448 cr₹1,887 cr₹1,525 cr₹897 cr
Tax expense₹79.1 cr₹457 cr₹227 cr₹254 cr
Effective tax rate17.7%24.2%14.9%28.3%
Net profit (PAT)₹386 cr₹1,013 cr₹1,023 cr₹463 cr
Net profit margin2.3%6.7%7.2%4.2%
Basic EPS₹2.82₹8.46₹8.55₹3.88
Diluted EPS₹2.82₹8.46₹8.54₹3.87

Revenue trend and demand read-through

Topline for Q1 FY27 came in at ₹4,292 cr against ₹3,910 cr in Q1 FY26, and ₹4,484 cr in the preceding Q4 FY26 quarter.

On a sequential basis revenue declined -4.3%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.

Total expenses for the quarter were ₹3,992 cr, or 93.0% of revenue, with operating profit declined -3.6% year on year.

Margins, tax and profitability

Net profit of ₹141 cr works out to a net margin of 3.3% compared with 0.8% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.

Below the operating line, BIOCON LIMITED. reported profit before tax of ₹128 cr, a tax charge of -₹9.2 cr (effective rate -7.2%), interest cost of ₹213 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.

Sequentially, net profit moved from ₹126 cr in Q4 FY26 to ₹141 cr in Q1 FY27, a change of +12.1%.

Trailing twelve months and annual context

Across the trailing four quarters BIOCON LIMITED. has generated revenue of ₹17,212 cr and net profit of ₹495 cr, a trailing net margin of 2.9%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.

On a full-year basis, FY26 revenue was ₹16,780 cr with net profit of ₹386 cr and EPS of ₹2.82, versus the prior year where revenue grew +11.5% and profit declined -61.9%.

What to watch in the next BIOCON quarter

For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.

BIOCON LIMITED. has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.

All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.

BIOCON results coverage

No results report published for BIOCON yet — our desk covers each quarter within minutes of the filing.

BIOCON quarterly results FAQs

What were BIOCON LIMITED. (BIOCON) Q1 FY27 results?

In Q1 FY27 (quarter ended 30 Jun 2026), BIOCON LIMITED. reported revenue of ₹4,292 cr and net profit of ₹141 cr, a change of +349.4% year on year on +9.8% revenue growth. EPS stood at ₹0.87.

What is BIOCON profit margin in Q1 FY27?

BIOCON LIMITED. posted a net profit margin of 3.3% and an operating margin of 7.0% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹17,212 cr and net profit ₹495 cr.

Did BIOCON results beat the previous quarter?

BIOCON LIMITED. net profit changed +12.1% quarter on quarter, from ₹126 cr in Q4 FY26 to ₹141 cr in Q1 FY27.

When are BIOCON LIMITED. (BIOCON) quarterly results?

BIOCON LIMITED. has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.

Where can I see BIOCON latest quarterly results?

Results coverage for BIOCON will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the BIOCON stock page.

What is BIOCON LIMITED. annual revenue and profit?

For FY26, BIOCON LIMITED. reported full-year revenue of ₹16,780 cr and net profit of ₹386 cr, with EPS of ₹2.82.

How many quarterly results has BIOCON declared recently?

Past results dates for BIOCON will be listed here from the exchange calendar.

Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.